These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15930711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A.
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mineral changes in a transgenic mouse model for osteogenesis imperfecta.
    Cassella JP, Pereira R, Prockop DJ, Ali SY.
    Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Osteogenesis imperfecta murine: interaction between type I collagen homotrimers.
    Kuznetsova N, McBride DJ, Leikin S.
    J Mol Biol; 2001 Jun 08; 309(3):807-15. PubMed ID: 11397098
    [Abstract] [Full Text] [Related]

  • 13. Collagen overglycosylation: a biochemical feature that may contribute to bone quality.
    Dominguez LJ, Barbagallo M, Moro L.
    Biochem Biophys Res Commun; 2005 Apr 29; 330(1):1-4. PubMed ID: 15781223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, Keene DR, Persikov AV, Leikin S, Marini JC.
    Hum Mutat; 2007 Apr 29; 28(4):396-405. PubMed ID: 17206620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS, Glorieux FH, Rauch F.
    Calcif Tissue Int; 2009 Mar 29; 84(3):203-9. PubMed ID: 19137231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.